Breast Cancer Research » Provectus http://breastcancerresearch.info Breast Cancer Treatment, Prevention, Screening And Procedures Tue, 21 Feb 2012 00:35:52 +0000 en hourly 1 http://wordpress.org/?v=3.3.1 Provectus Pharmaceuticals Completes Patient Accrual in Phase 2C Clinical Trial of PH-10 for Psoriasis http://breastcancerresearch.info/provectus-pharmaceuticals-completes-patient-accrual-in-phase-2c-clinical-trial-of-ph-10-for-psoriasis.html http://breastcancerresearch.info/provectus-pharmaceuticals-completes-patient-accrual-in-phase-2c-clinical-trial-of-ph-10-for-psoriasis.html#comments Mon, 30 May 2011 23:23:08 +0000 http://breastcancerresearch.info/provectus-pharmaceuticals-completes-patient-accrual-in-phase-2c-clinical-trial-of-ph-10-for-psoriasis.html Provectus Pharmaceuticals Completes Patient Accrual in Phase 2C Clinical Trial of PH-10 for Psoriasis
KNOXVILLE, Tenn.–(BUSINESS WIRE)–Provectus Pharmaceuticals has completed patient accrual in its Phase 2C clinical trial of PH-10 for psoriasis.

Read more on Business Wire

]]> http://breastcancerresearch.info/provectus-pharmaceuticals-completes-patient-accrual-in-phase-2c-clinical-trial-of-ph-10-for-psoriasis.html/feed 0 Provectus completes enrollment in first cohort of PV-10 Phase 1 trial for liver cancer http://breastcancerresearch.info/provectus-completes-enrollment-in-first-cohort-of-pv-10-phase-1-trial-for-liver-cancer.html http://breastcancerresearch.info/provectus-completes-enrollment-in-first-cohort-of-pv-10-phase-1-trial-for-liver-cancer.html#comments Wed, 15 Sep 2010 23:42:32 +0000 http://breastcancerresearch.info/provectus-completes-enrollment-in-first-cohort-of-pv-10-phase-1-trial-for-liver-cancer.html Provectus completes enrollment in first cohort of PV-10 Phase 1 trial for liver cancer
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that it has completed enrollment in the first of two dose cohorts in its Phase 1 clinical trial of PV-10 for liver cancer, and that the therapy was very well tolerated by all three subjects treated, with substantial evidence of efficacy.

Read more on News-Medical-Net

]]> http://breastcancerresearch.info/provectus-completes-enrollment-in-first-cohort-of-pv-10-phase-1-trial-for-liver-cancer.html/feed 0 Provectus Pharmaceuticals to Use Numoda’s TruPoints System to Facilitate Transactions with Potential Licensing … http://breastcancerresearch.info/provectus-pharmaceuticals-to-use-numodas-trupoints-system-to-facilitate-transactions-with-potential-licensing.html http://breastcancerresearch.info/provectus-pharmaceuticals-to-use-numodas-trupoints-system-to-facilitate-transactions-with-potential-licensing.html#comments Fri, 30 Jul 2010 00:38:42 +0000 http://breastcancerresearch.info/provectus-pharmaceuticals-to-use-numodas-trupoints-system-to-facilitate-transactions-with-potential-licensing.html Provectus Pharmaceuticals to Use Numoda’s TruPoints System to Facilitate Transactions with Potential Licensing …
KNOXVILLE, Tenn.—-Provectus Pharmaceuticals, Inc. , a development-stage oncology and dermatology biopharmaceutical company, has signed an agreement with Numoda Capital Innovations LLC to license its TruPoints® strategic partnering platform.

Read more on Business Wire via Yahoo! Finance

]]> http://breastcancerresearch.info/provectus-pharmaceuticals-to-use-numodas-trupoints-system-to-facilitate-transactions-with-potential-licensing.html/feed 0